A DOUBLE-BLIND TRIAL OF A SINGLE INTRAVENOUS DOSE OF METRONIDAZOLE AS PROPHYLAXIS AGAINST WOUND INFECTION FOLLOWING APPENDICECTOMYGREENALL MJ; BAKRAN A; PICKFORD IR et al.1979; BRIT. J. SURG.; GBR; DA. 1979; VOL. 66; NO 6; PP. 428-429; BIBL. 14 REF.Article

A PROSPECTIVE STUDY OF SUBCLAVIAN VEIN CATHETERS USED EXCLUSIVELY FOR THE PURPOSE OF INTRAVENOUS FEEDING.BLACKETT RL; BAKRAN A; BRADLEY JA et al.1978; BRIT. J. SURG.; G.B.; DA. 1978; VOL. 65; NO 6; PP. 393-395; BIBL. 9 REF.Article

Sites of stenosis in AV fistulae for haemodialysis accessSIVANESAN, S; HOW, T. V; BAKRAN, A et al.Nephrology, dialysis, transplantation (Print). 1999, Vol 14, Num 1, pp 118-120, issn 0931-0509Conference Paper

Characterizing flow distributions in AV fistulae for haemodialysis accessSIVANESAN, S; HOW, T. V; BAKRAN, A et al.Nephrology, dialysis, transplantation (Print). 1998, Vol 13, Num 12, pp 3108-3110, issn 0931-0509Article

Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipientsTONG, C. Y. W; CUEVAS, L; WILLIAMS, H et al.Journal of clinical microbiology (Print). 1998, Vol 36, Num 9, pp 2681-2685, issn 0095-1137Article

A preliminary experience with the human homologous vein graft for vascular accessGECIM, I. E; WARD, R. G; BAKRAN, A et al.Vascular surgery. 1996, Vol 30, Num 5, pp 395-398, issn 0042-2835Article

Cyclosporin-erythromycin interaction in renal transplant patientsGUPTA, S. K; BAKRAN, A; JOHNSON, R. W. G et al.British journal of clinical pharmacology. 1989, Vol 27, Num 4, pp 475-481, issn 0306-5251Article

Pharmacokinetics of cyclosporin: influence of rate-duration profile of an intravenous infusion in renal transplant patientsGUPTA, S. K; BAKRAN, A; JOHNSON, R. W. G et al.British journal of clinical pharmacology. 1989, Vol 27, Num 3, pp 353-357, issn 0306-5251Article

Bladder tumours in paraplegic patients on renal replacement therapyYAQOOB, M; MCCLELLAND, P; BELL, G. M et al.Lancet (British edition). 1991, Vol 338, Num 8782-3, pp 1554-1555, issn 0140-6736Article

Comparison of two commercial methods for measurement of cytomegalovirus load in blood samples after renal transplantationTONG, C. Y. W; CUEVAS, L. E; WILLIAMS, H et al.Journal of clinical microbiology (Print). 2000, Vol 38, Num 3, pp 1209-1213, issn 0095-1137Article

Erythromycin enhances the absorption of cyclosporinGUPTA, S. K; BAKRAN, A; JOHNSON, R. W. G et al.British journal of clinical pharmacology. 1988, Vol 25, Num 3, pp 401-402, issn 0306-5251Article

Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipientsMCLAUGHLIN, P. J; AIKAWA, A; DAVIES, H. M et al.Transplantation. 1991, Vol 51, Num 6, pp 1225-1229, issn 0041-1337, 5 p.Article

The relationship between calcium antagonist therapy and growth of T lymphocytes from human renal allograft biopsiesGECIM, I. E; CHRISTMAS, S. E; BREW, R et al.Transplantation. 1993, Vol 56, Num 4, pp 1015-1016, issn 0041-1337Article

Cadaveric renal transplantation with cyclosporine monotherapyAIKAWA, A; SELLS, R. A; BAKRAN, A et al.Transplantation proceedings. 1994, Vol 26, Num 4, pp 1915-1916, issn 0041-1345Conference Paper

Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipientsTONG, C. Y. W; BAKRAN, A; WILLIAMS, H et al.Transplantation. 2000, Vol 70, Num 1, pp 213-216, issn 0041-1337Article

Pregnancy does not adversely affect renal transplant functionCROWE, A. V; RUSTOM, R; GRADDEN, C et al.QJM (Oxford. 1994. Print). 1999, Vol 92, Num 11, pp 631-635, issn 1460-2725Article

A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipientsSELLS, R. A; BAKRAN, A; BROWN, M. W et al.Transplantation proceedings. 1998, Vol 30, Num 8, issn 0041-1345, p. 4098Conference Paper

Effect of sensitization on primary cadaveric renal allograft survival following deliberate unrelated blood transfusionsMARTIN, S; DYER, P. A; MANOS, J et al.Clinical transplantation. 1987, Vol 1, Num 6, pp 300-303, issn 0902-0063Article

Uromodulin levels are decreased in urine during acute tubular necrosis but not during immune rejection after renal transplantationMCLAUGHLIN, P. J; AIKAWA, A; DAVIES, H. M et al.Clinical science (1979). 1993, Vol 84, Num 2, pp 243-246, issn 0143-5221Article

Association of tumour necrosis factor alpha and interleukin 6 levels with cytomegalovirus DNA detection and disease after renal transplantationTONG, C. Y. W; BAKRAN, A; WILLIAMS, H et al.Journal of medical virology. 2001, Vol 64, Num 1, pp 29-34, issn 0146-6615Article

A prospective study of prophylactic ATG versus cyclosporine in regrafted and highly sensitized renal allograft recipientsPEARSON, R. C; JOHNSON, R. W. G; BAKRAN, A et al.Transplantation. 1990, Vol 50, Num 6, pp 1061-1063, issn 0041-1337, 3 p.Article

Proliferative responses to allogeneic HLA class I peptidesPARAOAN, M. T; SELLS, R. A; BAKRAN, A et al.Transplantation proceedings. 2001, Vol 33, Num 1-2, pp 334-335, issn 0041-1345Conference Paper

Analysis of factors affecting the outcome of renal transplantation in older peopleSHARMA, A. K; BROWN, M; CONNOLLY, J et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, issn 0041-1345, p. 261Conference Paper

Utility of the pp65 direct antigenemia test in the diagnosis of cytomegalovirus (CMV) in renal transplant recipientsSHARMA, A. K; TAYLOR, J. D; TONG, W et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, issn 0041-1345, p. 799Conference Paper

TNF staining of graft biopsies in renal transplantationAIKAWA, A; MCLAUGHLIN, P. J; MCDICKEN, I. W et al.Transplantation. 1993, Vol 56, Num 1, pp 231-233, issn 0041-1337Article